EBITDA for the period rose by 23.2% to Rs. 3,797 million
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Encourages working women to practice self-care
IMCD India’s innovative formulations bring the Skinification trend to life with cutting-edge solutions across beauty and personal care
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
Subscribe To Our Newsletter & Stay Updated